Table 2.
Potential advantages of bacteriophage treatment over antibiotic treatment.
| Characteristics features | Phage treatment | Antibiotics treatment | References |
|---|---|---|---|
| Specificity | Highly specific | Broad range of action | (37) |
| Effect on Normal flora | Minimal effect on normal flora with no dysbiosis and chances of developing secondary infections | Possess a broad spectrum of activities likely to affect microbial balance in patients and that are likely to generate severe secondary infections. | (38, 39) |
| Toxicity | Almost non-toxic | varying degrees of toxicity that range from mild to severe | (39–41) |
| Biofilm Penetration | Ability to penetrate effectively | cannot penetrate unless applied in large doses | (42–48) |
| Possibility of resistance | Reduced potential to induce bacterial resistance | High possibility of resistance | (39, 49–51) |
| Replication at the site of infection | Replicate at the infection site, making them accessible where they are most needed. | They do not always concentrate at the site of infection; instead, they are metabolized and excreted from the body. | (40, 50–52) |
| Adaptation to bacterial mutation | Can rapidly adapt to bacterial mutation | Unable to adjust to bacterial mutation | (40, 50) |
| Cross-resistance | Lack of cross-resistance to phages | Resistance mechanisms can also impact the effectiveness of various classes of antibiotics to a specific family of antibiotics. | (38, 39, 41, 50, 53, 54) |
| Dosage | Sometimes require multiple doses | Repeat doses are necessary | (40, 51) |
| Environment impact | Low impact on the environment | High environment impact | (40, 49, 55) |
| Effect on inflammatory responses | Possible effect on the inflammatory response | No effect on the inflammatory response | (56, 57) |
| Cycle of development | New phages (against phage-resistant bacteria) can rapidly be developed and be accomplished in days or weeks. | The long and expensive development cycle may take several years. | (55, 58) |